Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa I (1988) J Clin Invest 82: 322-30 Distinct roles for basal and induced COX-2 in podocyte injury. Cheng H, Fan X, Guan Y, Moeckel GW, Zent R, Harris RC (2009) J Am Soc Nephrol 20: 1953-62 Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome. Drukker A, Eddy AA (1998) J Am Soc Nephrol 9: 243-51 Lysis of cultured human melanoma M10 cells by polyclonal xenoantibodies to melanoma-associated antigens. Curry RA, Quaranta V, Pellegrino MA, Ferrone S (1981) Cancer Res 41: 463-6 Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A (1994) Kidney Int 45: 537-43 PPAR-gamma agonist protects podocytes from injury. Kanjanabuch T, Ma LJ, Chen J, Pozzi A, Guan Y, Mundel P, Fogo AB (2007) Kidney Int 71: 1232-9 Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis. Yang HC, Ma LJ, Ma J, Fogo AB (2006) Kidney Int 69: 1756-64 Puromycin aminonucleoside inhibits mesangial cell-induced contraction of collagen gels by stimulating production of reactive oxygen species. Zent R, Ailenberg M, Waddell TK, Downey GP, Silverman M (1995) Kidney Int 47: 811-7 Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats. Ma LJ, Jha S, Ling H, Pozzi A, Ledbetter S, Fogo AB (2004) Kidney Int 65: 106-15 Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries. Kawamura T, Yoshioka T, Bills T, Fogo A, Ichikawa I (1991) Kidney Int 40: 291-301 Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA (1991) Kidney Int 40: 1020-31 Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. Eddy AA, Michael AF (1988) Kidney Int 33: 14-23 Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA (1992) Am J Pathol 141: 1381-96 A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Eddy AA, McCulloch L, Liu E, Adams J (1991) Am J Pathol 138: 1111-23 Protective effects of PPARγ agonist in acute nephrotic syndrome. Zuo Y, Yang HC, Potthoff SA, Najafian B, Kon V, Ma LJ, Fogo AB (2012) Nephrol Dial Transplant 27: 174-81 Impaired renal mevalonate metabolism in nephrotic syndrome: a stimulus for increased hepatic cholesterogenesis independent of GFR and hypoalbuminemia. Golper TA, Swartz SH (1982) Metabolism 31: 471-6 Effects of podocyte injury on glomerular development. Ma J, Rossini M, Yang HC, Zuo Y, Fogo AB, Ichikawa I (2007) Pediatr Res 62: 417-21 Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside. Ma J, Matsusaka T, Yang HC, Zhong J, Takagi N, Fogo AB, Kon V, Ichikawa I (2011) Pediatr Res 70: 83-9 Serological, functional, and immunochemical characterization of a monoclonal antibody (MoAb Q2/70) to human Ia-like antigens. Quaranta V, Indiveri F, Glassy MC, Ng A, Russo C, Molinaro GA, Pellegrino MA, Ferrone S (1980) Hum Immunol 1: 211-23 Puromycin induces reversible proteinuric injury in transgenic mice expressing cyclooxygenase-2 in podocytes. Jo YI, Cheng H, Wang S, Moeckel GW, Harris RC (2007) Nephron Exp Nephrol 107: e87-94
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.